N4P N4 Pharma Plc

TIDMN4P

RNS Number : 2255W

N4 Pharma PLC

10 November 2017

10(th) November 2017

N4 Pharma plc (the "Company")

Notification of Transaction by Directors/PDMRs

The Company was notified on 10(th) November 2017 that a Person Discharging Management Responsibilities ("PDMR"), had purchased shares in the Company as set out below. Following this purchase, Nigel Theobald now has a total beneficial interest in 12,255,233 Ordinary Shares, representing 16.4% of the issued share capital of the Company.

The Company's share capital consists of 74,714,285 Ordinary Shares with voting rights.

 
 1      Details of the person discharging managerial 
         responsibilities/person closely associated 
-----  -------------------------------------------------------------- 
  a)     Name                           Nigel Theobald 
-----  -----------------------------  ------------------------------- 
 2      Reason for the notification 
-----  -------------------------------------------------------------- 
  a)     Position/status               CEO and Director 
-----  -----------------------------  ------------------------------- 
  b)     Initial notification/         Initial notification 
          Amendment 
-----  -----------------------------  ------------------------------- 
 3      Details of the issuer, emission allowance market 
         participant, auction platform, auctioneer or 
         auction monitor 
-----  -------------------------------------------------------------- 
  a)     Name                          N4 Pharma Plc 
-----  -----------------------------  ------------------------------- 
  b)     LEI                           213800I841D2RKMFK955 
-----  -----------------------------  ------------------------------- 
 4      Details of the transaction(s): section to be 
         repeated for (i) each type of instrument; (ii) 
         each type of transaction; (iii) each date; 
         and (iv) each place where transactions have 
         been conducted 
-----  -------------------------------------------------------------- 
  a)     Description                   Oridinary shares BGP 0.0004 
          of the financial              ISIN code GB00BYW8QM32 
          instrument, 
          type of instrument 
          Identification 
          code 
-----  -----------------------------  ------------------------------- 
  b)     Nature of the                 Direct purchase of shares 
          transaction 
-----  -----------------------------  ------------------------------- 
 c)     Price(s) and                         Price           volume 
         volume(s) 
-----  -----------------------------  -------------------  ---------- 
                         GBP0.07925                          56,656 
  -------------------------------------------------------  ---------- 
 d)     Aggregated                     n/a 
         information 
         - Aggregated 
         price 
         - Aggregated 
         volume 
         - Aggregated 
         total 
-----  -----------------------------  ------------------------------- 
  e)     Date of the                   10(th) November 2017 
          transaction 
-----  -----------------------------  ------------------------------- 
  f)     Place of the                  London Stock Exchange, AIM 
          transaction 
-----  -----------------------------  ------------------------------- 
 g)     Additional 
         Information 
-----  --------------------------------------------------  ---------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEAKFEFEDXFFF

(END) Dow Jones Newswires

November 10, 2017 11:04 ET (16:04 GMT)

N4 Pharma (LSE:N4P)
Historical Stock Chart
From Apr 2024 to May 2024

N4 Pharma (LSE:N4P)
Historical Stock Chart
From May 2023 to May 2024